Insider Transactions in Q4 2021 at Staar Surgical CO (STAA)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 14
2021
|
Keith Holliday Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
6,000
-26.41%
|
$534,000
$89.57 P/Share
|
Nov 18
2021
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-35.58%
|
$3,955,000
$113.83 P/Share
|
Nov 18
2021
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+26.24%
|
$245,000
$7.76 P/Share
|
Nov 17
2021
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-35.58%
|
$3,955,000
$113.83 P/Share
|
Nov 17
2021
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+26.24%
|
$245,000
$7.76 P/Share
|
Nov 16
2021
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-35.58%
|
$3,990,000
$114.2 P/Share
|
Nov 16
2021
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+26.24%
|
$245,000
$7.76 P/Share
|
Oct 04
2021
|
Samuel J Gesten Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,000
-35.23%
|
$1,710,000
$114.53 P/Share
|
Oct 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
0
|
-
|
Oct 01
2021
|
Broadwood Partners, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
71,577
-0.83%
|
-
|